Celularity Inc (CELU)
Nasdaq · Pharmaceutical Preparations · Inc. DE
What they're doing
Between 2026-06-21 and 2026-09-19, public records show 3 signals for Celularity Inc. Most notable: 2026-06-25: Filed 8-K disclosing director or officer change; 2026-06-30: Filed 8-K disclosing material agreement, director or officer change; 2026-08-07: Filed 8-K disclosing director or officer change. Federal contract obligations over the last 24 months total $0. This summary was assembled automatically from SEC EDGAR, USAspending.gov, U.S. Senate lobbying disclosures and Wikimedia pageview counts.
Generated 2026-09-19 from public records.
Signals, last 12 months
- Material 8-K filingFiled 8-K disclosing director or officer change
- Material 8-K filingFiled 8-K disclosing material agreement, director or officer change
- Material 8-K filingFiled 8-K disclosing director or officer change
- Material 8-K filingFiled 8-K disclosing director or officer change
- Material 8-K filingFiled 8-K disclosing material agreement
- Material 8-K filingFiled 8-K disclosing material agreement, director or officer change
- Material 8-K filingFiled 8-K disclosing material agreement
- Material 8-K filingFiled 8-K disclosing director or officer change
- Material 8-K filingFiled 8-K disclosing director or officer change
- Material 8-K filingFiled 8-K disclosing material agreement
- Material 8-K filingFiled 8-K disclosing material agreement
Insider transactions
| Date | Insider | Role | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-04-13 | Brigido Stephen | officer | F | 268 | 1.28 | $343 |
| 2026-04-13 | Brigido Stephen | officer | M | 821 | 0 | $0 |
| 2026-04-13 | Haines John R | officer | M | 1,641 | 0 | $0 |
| 2026-04-13 | Haines John R | officer | F | 583 | 1.28 | $746 |
| 2026-04-13 | Hariri Robert J | director | M | 3,281 | 0 | $0 |
| 2026-04-13 | Hariri Robert J | director | F | 1,182 | 1.28 | $1,513 |
| 2026-01-12 | Parks Diane L. | director | A | 30,000 | 0 | $0 |
| 2026-01-12 | Diamandis Peter | director | A | 20,385 | 0 | $0 |
| 2026-01-12 | Ling Geoffrey M.D. | director | A | 19,231 | 0 | $0 |
| 2026-01-12 | LeVien Vincent | director | A | 28,847 | 0 | $0 |
| 2026-01-12 | Ling Geoffrey M.D. | director | A | 19,231 | 0 | $0 |
| 2026-01-12 | LeVien Vincent | director | A | 28,847 | 0 | $0 |
| 2026-01-12 | Diamandis Peter | director | A | 20,385 | 0 | $0 |
| 2026-01-12 | Parks Diane L. | director | A | 30,000 | 0 | $0 |
| 2025-12-29 | LeVien Vincent | director | A | 125,000 | 0 | $0 |
| 2025-12-29 | Ling Geoffrey M.D. | director | A | 125,000 | 0 | $0 |
| 2025-12-29 | Parks Diane L. | director | A | 125,000 | 0 | $0 |
| 2025-12-29 | Diamandis Peter | director | A | 125,000 | 0 | $0 |
| 2025-12-19 | Parks Diane L. | director | A | 67,416 | 0 | $0 |
| 2025-12-19 | Ling Geoffrey M.D. | director | A | 67,416 | 0 | $0 |
| 2025-12-19 | Diamandis Peter | director | A | 67,416 | 0 | $0 |
| 2025-11-19 | Parks Diane L. | director | A | 61,539 | 0 | $0 |
| 2025-11-19 | LeVien Vincent | director | A | 3,699 | 0 | $0 |
| 2025-11-19 | Ling Geoffrey M.D. | director | A | 44,379 | 0 | $0 |
| 2025-11-19 | Diamandis Peter | director | A | 47,042 | 0 | $0 |
| 2025-04-13 | Hariri Robert J | director | F | 1,154 | 1.64 | $1,893 |
| 2025-04-13 | Hariri Robert J | director | M | 3,281 | 0 | $0 |
| 2025-04-13 | Beers David C | officer | M | 1,025 | 0 | $0 |
| 2025-04-13 | Beers David C | officer | F | 360 | 1.64 | $590 |
| 2025-04-13 | Brigido Stephen | officer | F | 268 | 1.64 | $440 |
| 2025-04-13 | Haines John R | officer | F | 577 | 1.64 | $946 |
| 2025-04-13 | Hariri Robert J | director | F | 1,154 | 1.64 | $1,893 |
| 2025-04-13 | Hariri Robert J | director | M | 3,281 | 0 | $0 |
| 2025-04-13 | Haines John R | officer | M | 1,641 | 0 | $0 |
| 2025-04-13 | Brigido Stephen | officer | M | 820 | 0 | $0 |
| 2025-02-17 | Brigido Stephen | officer | F | 3,272 | 2.14 | $7,002 |
| 2025-02-17 | Brigido Stephen | officer | M | 10,000 | 0 | $0 |
| 2025-02-17 | Beers David C | officer | F | 4,396 | 2.14 | $9,407 |
| 2025-02-17 | Beers David C | officer | M | 12,500 | 0 | $0 |
| 2025-02-17 | Haines John R | officer | F | 7,035 | 2.14 | $15,055 |
| 2025-02-17 | Haines John R | officer | M | 20,000 | 0 | $0 |
| 2025-01-24 | Genting Berhad | ten percent owner | X | 535,274 | 2.07 | $1,108,017 |
| 2025-01-24 | Genting Berhad | ten percent owner | X | 652,981 | 2.07 | $1,351,671 |
| 2024-12-19 | Diamandis Peter | director | A | 67,416 | 0 | $0 |
| 2024-12-19 | Parks Diane L. | director | A | 67,416 | 0 | $0 |
| 2024-12-19 | Ling Geoffrey M.D. | director | A | 67,416 | 0 | $0 |
| 2024-12-19 | BERMAN RICHARD J | director | A | 67,416 | 0 | $0 |
| 2024-12-19 | Kehler Dean C | director | A | 67,416 | 0 | $0 |
| 2024-12-19 | Diamandis Peter | director | A | 67,416 | 0 | $0 |
Federal contracts
No federal contract actions on record for this recipient mapping.
Lobbying
No federal lobbying filings on record for this client mapping.
Public attention
No Wikipedia pageview data linked to this company.
Recent filings
- 2026-09-14 8-K
- 2026-08-14 NT 10-Q
- 2026-08-07 8-K
- 2026-07-29 8-K
- 2026-07-22 25-NSE
- 2026-06-30 8-K
- 2026-06-25 8-K
- 2026-06-23 4
- 2026-06-23 4
- 2026-06-23 4
- 2026-06-23 SCHEDULE 13D/A
- 2026-06-12 8-K
- 2026-06-03 8-K
- 2026-05-28 8-K
- 2026-05-15 NT 10-Q
- 2026-04-30 10-K
- 2026-04-24 3
- 2026-04-24 3
- 2026-04-24 3
- 2026-04-22 SCHEDULE 13D/A